Identifying circulating glioma cells and their clusters as diagnostic markers by a novel detection platform
Clin Transl Med
.
2021 Feb;11(2):e318.
doi: 10.1002/ctm2.318.
Authors
Yangzhi Qi
1
2
,
Qian Sun
1
2
,
Gang Deng
1
2
,
Huikai Zhang
1
2
,
Yang Xu
1
2
,
Yuane Li
3
,
Shaoyi Huang
3
,
Yong Li
1
2
,
Zhang Ye
1
2
,
Yixuan Wang
1
2
,
Fanen Yuan
1
2
,
Ping Hu
1
2
,
Lun Gao
1
2
,
Hongxiang Jiang
1
2
,
Wenya Wu
3
,
Baohui Liu
1
2
,
Qianxue Chen
1
2
Affiliations
1
Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, P.R. China.
2
Key laboratory of Renmin hospital, Wuhan University, Wuhan, Hubei, P.R. China.
3
Department of Circulating Tumor Cells, YZY Medical Technological Company, Wuhan, Hubei, P.R. China.
PMID:
33634975
PMCID:
PMC7862585
DOI:
10.1002/ctm2.318
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers
Cell Line, Tumor
Glioma / diagnosis*
Humans
Neoplastic Cells, Circulating*
Sensitivity and Specificity
Substances
Biomarkers